Has the burden of depression been overestimated? by Michelle E. Kruijshaar, Nancy Hoeymans, Jan Spijker, Marlies E.A. Stouthard, Marie-Louise Essink-Bot

Get full text

Positive association between physical outcomes and patient-reported outcomes in late-onset Pompe disease: a cross sectional study by Meng Yuan, Eleni-Rosalina Andrinopoulou, Michelle E. Kruijshaar, Aglina Lika, Laurike Harlaar, Ans T. van der Ploeg, Dimitris Rizopoulos, Nadine A. M. E. van der Beek

Get full text

Enzyme replacement therapy reduces the risk for wheelchair dependency in adult Pompe patients by Jan C. van der Meijden, Michelle E. Kruijshaar, Dimitris Rizopoulos, Pieter A. van Doorn, Nadine A. M. E. van der Beek, Ans T. van der Ploeg

Get full text

Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in adult patients with Pompe disease by Tim A. Kanters, Ans T. van der Ploeg, Michelle E. Kruijshaar, Dimitris Rizopoulos, W. Ken Redekop, Maureen P. M. H. Rutten-van Mӧlken, Leona Hakkaart-van Roijen

Get full text

The ACE I/D polymorphism does not explain heterogeneity of natural course and response to enzyme replacement therapy in Pompe disease. by Esther Kuperus, Jan C van der Meijden, Stijn L M In 't Groen, Marian A Kroos, Marianne Hoogeveen-Westerveld, Dimitris Rizopoulos, Monica Yasmin Nino Martinez, Michelle E Kruijshaar, Pieter A van Doorn, Nadine A M E van der Beek, Ans T van der Ploeg, W W M Pim Pijnappel

Get full text